Published August 1, 2008 | Version v1
Journal article

Effects of coumestrol on lipid and glucose metabolism as a farnesoid X receptor ligand

  • 1. Basic Research Activities of Innovative Biosciences, Tokyo 105-0001 (Japan)
  • 2. Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497 (Japan)
  • 3. Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Science, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657 (Japan)
  • 4. School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Kyuban-cho, Koshien, Nishinomiya, Hyogo 663-8179 (Japan)

Description

In the course of an effort to identify novel agonists of the farnesoid X receptor (FXR), coumestrol was determined to be one such ligand. Reporter and in vitro coactivator interaction assays revealed that coumestrol bound and activated FXR. Treatment of Hep G2 cells with coumestrol stimulated the expression of FXR target genes, thereby regulating the expression of target genes of the liver X receptor and hepatocyte nuclear factor-4α. Through these actions, coumestrol is expected to exert beneficial effects on lipid and glucose metabolism

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2008.04.136

Additional details

Identifiers

DOI
10.1016/j.bbrc.2008.04.136;
PII
S0006-291X(08)00842-5;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
372
Journal Issue
3
Journal Page Range
p. 395-399
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.